INDCHEMIE HEALTH
GenericsINDCHEMIE HEALTH is a generic drug manufacturer focused on Infectious Disease, Cardiovascular, Gastroenterology.
INDCHEMIE HEALTH's Key Drugs
INDCHEMIE HEALTH's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
INDCHEMIE HEALTH's Recent FDA Approvals
New NDA/BLA approvals for INDCHEMIE HEALTH over the last two years — novel drugs only, excluding generics and label supplements.
INDCHEMIE HEALTH's Therapeutic Areas
INDCHEMIE HEALTH's approved drugs and pipeline span 3 therapeutic areas, led by Infectious Disease and Cardiovascular. Weighted by commercial stage — approved drugs count most, then late-stage trials.
INDCHEMIE HEALTH's Top Competitors
INDCHEMIE HEALTH's closest competitors by therapeutic-area and drug-target overlap include APOTHECON, WAYLIS THERAP, and Merck. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
INDCHEMIE HEALTH Pipeline Snapshot
Active clinical trials for INDCHEMIE HEALTH across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Infectious Disease pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2015-07-29
- Latest
- 2024-08-27
- Applications
- 2